Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Wichita, KA
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
New Orleans, LA
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Duluth, MN
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Rochester, MN
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Saint Cloud, MN
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Omaha, NE
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Bismarck, ND
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Fargo, ND
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Grand Forks, ND
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Toledo, OH
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Danville, PA
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Rapid City, SD
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Sioux Falls, SD
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
mi
from
Regina,
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
Allan Blair Cancer Centre
mi
from
Regina,
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Oakland, CA
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Washington,
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Jacksonville, FL
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Miami, FL
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
University of Miami Batchelor Children's Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Chicago, IL
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
New Orleans, LA
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Louisiana State University Children's Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Ann Arbor, MI
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Hackensack, NJ
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Durham, NC
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Duke University Medical Center Children's Hospital
mi
from
Durham, NC
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Philadelphia, PA
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Charleston, SC
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Dallas, TX
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
San Antonio, TX
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Texas Transplant Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated:  7/28/2016
mi
from
Montreal,
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Sibling Donor Cord Blood Banking and Transplantation
Status: Enrolling
Updated: 7/28/2016
Hopital Ste-Justine
mi
from
Montreal,
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Davis, CA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Davis, CA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Lakewood, CO
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Atlanta, GA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Augusta, GA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
New Orleans, LA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Boston, MA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Springfield, MA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Detroit, MI
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Mineola, NY
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
New York, NY
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Toledo, OH
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Houston, TX
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Burlington, VT
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Norfolk, VA
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Curitiba,
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
mi
from
Curitiba,
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Los Angeles, CA
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Mather, CA
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Mather, CA
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Stanford, CA
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Stamford, CT
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Bay Pines, FL
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Bay Pines, FL
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Ocala, FL
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Shreveport, LA
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials